General Information

Mail: University of Houston
Cullen College of Engineering
E421 Engineering Bldg 2, Houston, TX 77204-4007
Map & Driving Directions (includes parking information)
Email: info [at] egr [dot] uh [dot] edu

News

Meet Cullen College Alumna Tracy Ngu, Process Engineer at Technip USA

Printer-friendly versionSend by emailPDF version

Tracy Ngu graduated with a B.S. in Chemical Engineering from the UH Cullen College of Engineering in May 2012. She now works as a process engineer at Technip USA here in Houston.

While at the Cullen College, Tracy was an active member of the PROMES (Program for Mastery in Engineering Studies) Program, which offers specialized curricula that emphasizes academic success strategies and personal and professional skills development.

PROMES students participate in peer-led collaborative learning workshops supporting math, science, and engineering courses. Upper division students facilitate these workshops and receive stipends in return for their service. Tracy served as an assistant facilitator for the Chemical Transport and Chemical Processes PROMES workshops during her time in the PROMES Program, explaining that it helped her to gain confidence, overcome her shyness, and meet new friends.

"These programs are great, and I do recommend engineering students to join upon entering the university," Tracy said. "I wouldn’t have met most of my friends if it was not for PROMES. PROMES allowed me to interact with different engineering disciplines."

To read Tracy Ngu's full alumna profile, please visit: http://www.sep.uh.edu/student-successes/alumni/tracy-ngu.php.

Department: 

Centers/Programs: 

Related News Stories

Researcher Publishes Paper on Engineered Antibody that Targets Acute Myeloid Leukemia

Almost 19,000 new cases of acute myeloid leukemia and 10,500 deaths from the blood and bone marrow cancer could strike Americans this year, according to the American Cancer Society. Chemotherapy, when used as primary treatment, is successful in about 65 percent of patients with the cancer, and remission rates vary depending on patients’ individual characteristics, according to the organization.